American Journal of Clinical Nutrition, Vol 47, 157-160, Copyright © 1988 by The American Society for Clinical Nutrition, Inc

REVIEW ARTICLES

Hyperlipidemia and the progression of renal disease

WF Keane, BL Kasiske and MP O'Donnell
Department of Medicine, University of Minnesota Medical School, Minneapolis 55415.

Focal glomerulosclerosis (FGS) is commonly seen in human and in experimental models of chronic renal disease. Although considerable experimental data suggest that hypertension is important in progressive nephron damage, recent studies also have indicated that abnormal lipid metabolism may be an independent risk factor in the pathogenesis of FGS. Indeed, the synergistic impact of hypertension and hyperlipidemia in the pathogenesis of FGS may be analogous to the role of these factors in the pathogenesis of atherosclerosis. This review focuses on some of the recent and pertinent data that support a role of lipid- mediated glomerular injury in the pathogenesis of progressive renal disease.

This article has been cited by other articles:

				C. Musso, E. Javor, E. Cochran, J. E Balow, and P. Gorden Spectrum of Renal Diseases Associated with Extreme Forms of Insulin Resistance Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 616 - 622. [Abstract] [Full Text] [PDF]

				A. R. Chade, A. Lerman, and L. O. Lerman Kidney in Early Atherosclerosis Hypertension, June 1, 2005; 45(6): 1042 - 1049. [Abstract] [Full Text] [PDF]

				V G Athyros, D P Mikhailidis, A A Papageorgiou, A N Symeonidis, A N Pehlivanidis, V I Bouloukos, and M Elisaf The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study J. Clin. Pathol., July 1, 2004; 57(7): 728 - 734. [Abstract] [Full Text] [PDF]

				M. Elisaf and D. P. Mikhailidis Statins and Renal Function Angiology, September 1, 2002; 53(5): 493 - 502. [Abstract] [PDF]

				V. A. Valentino, M. D. Wilson, W. Weart, and G. L. Bakris A Perspective on Converting Enzyme Inhibitors and Calcium Channel Antagonists in Diabetic Renal Disease Arch Intern Med, December 1, 1991; 151(12): 2367 - 2372. [Abstract] [PDF]

				J. D. Hanna, J. W. Foreman, and J. C.M. Chan Chronic Renal Insufficiency in Infants and Children Clinical Pediatrics, June 1, 1991; 30(6): 365 - 384. [PDF]

				J. V. Selby, S. C. Fitz-Simmons, J. M. Newman, P. P. Katz, S. Sepe, and J. Showstack The Natural History and Epidemiology of Diabetic Nephropathy: Implications for Prevention and Control JAMA, April 11, 1990; 263(14): 1954 - 1960. [Abstract] [PDF]

				W. F. Keane, S. Anderson, M. Aurell, D. de Zeeuw, R. G. Narins, and G. Povar Angiotensin Converting Enzyme Inhibitors and Progressive Renal Insufficiency: Current Experience and Future Directions Ann Intern Med, September 15, 1989; 111(6): 503 - 516. [Abstract] [PDF]